Penumbra (PEN) News & Sentiment

Penumbra is just beginning its mission to provide its unique thrombectomy technologies to patients in the United States and other countries.

ALAMEDA, Calif., Feb. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a top company in thrombectomy, shared today that Don Kassing will retire from the board of directors on April 1, 2025, after 17 years of dedicated service.

Penumbra (PEN) could see an increase in value due to rising confidence in its earnings potential, as shown by its upgrade to a Zacks Rank #2 (Buy).

Penumbra has announced that its earnings and revenues for the fourth quarter of 2024 were higher than anticipated.

Penumbra, Inc. (NYSE:PEN) will hold its Q4 2024 Earnings Conference Call on February 18, 2025, at 4:30 PM ET. The call will feature company representatives including Cecilia Furlong, Adam Elsesser, Maggie Yuen, and Jason Mills, along with various participants from different financial institutions. The operator for the call is Rob, who will assist with the proceedings.

The main figures for Penumbra (PEN) provide an overview of the company's performance for the quarter that ended in December 2024. However, it could be useful to compare some important metrics with Wall Street predictions and the results from the same period last year.

PEN is still drawing the attention of investors due to its impressive growth in its portfolio and its efforts to expand worldwide.

ALAMEDA, Calif., Jan. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) has announced that it will hold a conference call to review its financial results for the fourth quarter and the entire year of 2024. This call is scheduled for Tuesday, February 18, 2025, at 4:30 PM Eastern Time, after the market closes.

Penumbra (PEN) is likely to do better than the market because it shows strong growth in its financial performance.